Daly Richard J

President and CEO, DirectorCATALYST PHARMACEUTICALS, INC. (CPRX) · full profile →Form 4 · filed Jul 17, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
11
1 non-derivative · 10 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 15, 2026Disposed to issuer(D)271K$31.50$8.5M0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 15, 2026Disposed to issuer(D)34K$00
Jul 15, 2026Disposed to issuer(D)30K$00
Jul 15, 2026Disposed to issuer(D)20K$00
Jul 15, 2026Disposed to issuer(D)15K$00
Jul 15, 2026Disposed to issuer(D)1.4M$00
Jul 15, 2026Disposed to issuer(D)491K$00
Jul 15, 2026Disposed to issuer(D)382K$00
Jul 15, 2026Disposed to issuer(D)126K$00
Jul 15, 2026Disposed to issuer(D)40K$00
Jul 15, 2026Disposed to issuer(D)115K$00

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001161697-26-000173) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.